« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 14, Issue 5
, Pages 576-582
, May 2008
IV Busulfan Dose Individualization in Children undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies
References
- Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant. 1996;17:225–230
- . Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens. Semin Oncol. 1993;20:18–25
- Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant. 1995;16:31–42
- Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood. 1997;89:3055–3060
- . Gas chromatographic determination of busulfan in plasma with electron-capture detection. J Chromatogr A. 1983;277:374–380
- . Determination of busulfan in human plasma by gas chromatography with electron-capture detection. J Chromatogr A. 1988;425:303–309
- . Measurement of plasma busulfan concentration by high-performance liquid chromatography with ultraviolet detection. Ther Drug Monit. 1997;19:169–174
- . A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan. Biol Blood Marrow Transplant. 2002;8:619–624
- . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310
- . Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study. Cancer Chemother Pharmacol. 2006;57:191–198
PII: S1083-8791(08)00111-0
doi: 10.1016/j.bbmt.2008.03.002
© 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 14, Issue 5
, Pages 576-582
, May 2008
